Artiva Biotherapeutics, Inc. Common Stock

ARTVNASDAQUSD
8.61 USD
0.30 (3.32%)🟢LIVE (AS OF 12:29 PM EDT)
🟢Market: OPEN

ARTV is currently priced at $8.61. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics suggest ARTV is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Sep 15, 2026.

Open?$8.89
High?$9.02
Low?$8.56
Prev. Close?$8.91
Volume?196.0K
Avg. Volume?304.4K
VWAP?$8.73
Rel. Volume?0.64x
Bid / Ask
Bid?$8.68 × 100
Ask?$8.71 × 100
Spread?$0.03
Midpoint?$8.70
Valuation & Ratios
Market Cap?435.6M
Shares Out?48.9M
Float?13.6M
Float %?27.9%
P/E Ratio?N/A
P/B Ratio?1.25
EPS?-$1.86
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).
Employees
115
Market Cap
435.6M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2024-07-19
Address
5505 MOREHOUSE DRIVE
SAN DIEGO, CA 92121
Phone: (858) 267-4467
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+1/3)
Medium-Term (Wave)? Bearish(-3/3)
Short-Term (Ripple)? Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
59
Piotroski F-Score?0/9Weak
Altman Z-Score?11.17Safe
Confidence?41%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?13.47%High
Short Interest?1.8M
Days to Cover?6.7
Free Float13.6M
Avg Daily Volume273.7K
Settlement Date2026-08-31
Financial Health
Current Ratio?24.16Strong
Quick Ratio?24.16Strong
Cash Ratio?20.67Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A
P/B?
Peers
100
S&P
92
1.25CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
S&P
97
-1.4CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
S&P
7
-26.1%WEAK
ROA?
S&P
3
-24.6%WEAK
Cash Flow & Enterprise
FCF?$-76910000
Enterprise Value?$134.2M
Fundamentals ratios updated end of day